Peripheral Mononuclear Cells Metabolomics in Obstructive Sleep Apnea Syndrome (OSAS): An Exploratory Pilot Study of Immunometabolic Signatures
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177658 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nour Balasan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", 34137 Trieste, Italy. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Metabolomics, Leukocytes, Mononuclear, Metabolome. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Italian Ministry of Health.
Abstract (Originalsprache)
Obstructive Sleep Apnea Syndrome (OSAS) is associated with systemic inflammation and immune dysfunction, yet the specific metabolic alterations within immune cells remain poorly understood. In this exploratory study, we characterized the metabolome of peripheral mononuclear cells (PMNCs) from patients with OSAS and healthy controls to investigate potential immunometabolic signatures associated with the disease. Initial analyses identified 21 nominally differentially abundant metabolites between OSAS patients and controls, suggesting trends such as the depletion of carnitines and alterations in fatty acid and neurotransmitter metabolism. However, following correction for multiple testing (False Discovery Rate, FDR), only putatively annotated cis,cis-muconic acid remained statistically significant. Furthermore, pathway enrichment analysis highlighted exploratory trends primarily associated with SLC-mediated transmembrane transport and energy metabolism. Our findings indicate that while OSAS PMNCs exhibit metabolic shifts suggestive of cellular stress, most of these alterations represent nominal trends that require validation in larger cohorts. The robust identification of putatively annotated cis,cis-muconic acid highlights a potential target of interest. In this exploratory pilot study, given the absence of polysomnographic and objective hypoxia parameters in most participants, observed metabolic alterations are described as associated with, rather than directly caused by, intermittent hypoxia. Overall, this study provides a hypothesis-generating framework for future research on the immunometabolic consequences of OSAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", 34137 Trieste, Italy.
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.
ORCID-Profile: Michela Zorzi, Antonietta Robino, Paolo Dalena, Mariateresa Di Stazio, Adamo Pio d'Adamo, Alberto Tommasini, Egidio Barbi, Feras Kharrat
Förderung
- Ministry of Health
- Italian Ministry of Health
Zitieren
APA
Balasan, N., Zorzi, M., Ura, B., Robino, A., Dalena, P., Addobbati, R., Stazio, M. D., Zago, A., Pio d'Adamo, A., Grasso, D. L., Tommasini, A., Barbi, E., & Kharrat, F. (2026). Peripheral Mononuclear Cells Metabolomics in Obstructive Sleep Apnea Syndrome (OSAS): An Exploratory Pilot Study of Immunometabolic Signatures. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177658
Vancouver
Balasan N, Zorzi M, Ura B, Robino A, Dalena P, Addobbati R, et al. Peripheral Mononuclear Cells Metabolomics in Obstructive Sleep Apnea Syndrome (OSAS): An Exploratory Pilot Study of Immunometabolic Signatures. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177658
BibTeX
@article{Balasan2026,
author = {Balasan, Nour and Zorzi, Michela and Ura, Blendi and Robino, Antonietta and Dalena, Paolo and Addobbati, Riccardo and Stazio, Mariateresa Di and Zago, Alessandro and Pio d'Adamo, Adamo and Grasso, Domenico Leonardo and Tommasini, Alberto and Barbi, Egidio and Kharrat, Feras},
title = {Peripheral Mononuclear Cells Metabolomics in Obstructive Sleep Apnea Syndrome (OSAS): An Exploratory Pilot Study of Immunometabolic Signatures},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177658}
}
EUVIMED